GSK lays off 650 staffers amid closure of German vaccine manufacturing site
GSK is consolidating its vaccine manufacturing operations to one site—located in Canada—amid what a spokesperson said is “decreasing demand” for egg-based flu shots.
GSK is consolidating its vaccine manufacturing operations to one site—located in Canada—amid what a spokesperson said is “decreasing demand” for egg-based flu shots.
comments(0)
5-min edit window · permanent after that